Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial ; volume:13 ; number:1 ; day:10 ; month:10 ; year:2022 ; pages:1-12 ; date:12.2022
Nature Communications ; 13, Heft 1 (10.10.2022), 1-12, 12.2022
- Creator
-
Motzer, Robert J.
Martini, Jean-François
Mu, Xinmeng J.
Staehler, Michael
George, Daniel J.
Valota, Olga
Lin, Xun
Pandha, Hardev S.
Ching, Keith A.
Ravaud, Alain
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-33555-8
- URN
-
urn:nbn:de:101:1-2022122721230530472543
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Motzer, Robert J.
- Martini, Jean-François
- Mu, Xinmeng J.
- Staehler, Michael
- George, Daniel J.
- Valota, Olga
- Lin, Xun
- Pandha, Hardev S.
- Ching, Keith A.
- Ravaud, Alain
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors